Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

SELDI ProteinChip array in oncoproteomic research.

Tai-Tung Yip1, Lee Lomas

  • 1Ciphergen Biosystems Inc, 6611 Dumbarton Circle, Fremont, CA 94555, USA. tyip@ciphergen.com

Technology in Cancer Research & Treatment
|March 11, 2003
PubMed
Summary

Proteomics and ProteinChip Array technology aid in discovering cancer biomarkers for early detection and improved treatment. This review highlights key examples of this technology

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optimized conditions for a quantitative SELDI TOF MS protein assay.

Methods in molecular biology (Clifton, N.J.)·2011
Same author

A novel proteomic biomarker panel as a diagnostic tool for patients with ovarian cancer.

Gynecologic oncology·2011
Same author

Proteomic biomarkers for overall and progression-free survival in ovarian cancer patients.

Proteomics. Clinical applications·2010
Same author

A proteomics panel for predicting optimal primary cytoreduction in stage III/IV ovarian cancer.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2009
Same author

Platelets actively sequester angiogenesis regulators.

Blood·2008
Same author

Three new potential ovarian cancer biomarkers detected in human urine with equalizer bead technology.

Acta obstetricia et gynecologica Scandinavica·2008

Area of Science:

  • Oncology
  • Proteomics
  • Biomarker Discovery

Background:

  • Cancer research heavily relies on understanding causes, early detection, and treatment.
  • Proteomic-based methodologies are crucial for advancing cancer diagnostics and therapeutics.
  • Early cancer detection significantly improves treatment efficacy.

Purpose of the Study:

  • To introduce the ProteinChip Array technology for clinical proteomics.
  • To highlight the role of this technology in cancer biomarker discovery and validation.
  • To showcase examples of cancer biomarker discoveries using this platform.

Main Methods:

  • Utilizes ProteinChip Array technology for clinical proteomics.
  • Focuses on discovery, validation, and characterization of cancer biomarkers.
  • Reviews specific examples of biomarker discoveries in cancer progression.

Main Results:

  • ProteinChip Array technology facilitates comprehensive cancer biomarker analysis.
  • The technology supports biomarker identification across all cancer stages.
  • Demonstrates potential for earlier cancer detection through biomarker discovery.

Conclusions:

  • ProteinChip Array technology is a valuable tool in clinical proteomics for cancer research.
  • Early identification of cancer biomarkers using this platform can lead to more effective treatments.
  • The technology offers a promising approach for advancing cancer care through biomarker-driven strategies.

Related Experiment Videos